baber/WOPTO huggingface dataset:
Patent DK-2285138-T3 (DK)
Inventor: CHRISTENSEN KAARE TAIS
IPC: H01Q1/22
Filed: 2005-02-16
Granted: 2013-07-01
Abstract: The invention regards a communication device which is adapted for placement in a users ear. The communication device comprises a shell part enclosing an input transducer for receiving an input signal, a signal processing device and an output transducer for providing a signal perceivable as sound, a battery located at a surface part of the shell which is facing away from the head of the user, a transmission and reception circuit for transmission and/or reception of electromagnetic energy. According to the invention an antenna for radiating and/or receiving electromagnetic energy is provided such that it has a first surface turned towards the surroundings and a second surface located in close proximity of the battery.
Patent DK-3044319-T3 (DK)
Inventor: DICKSON GEORGE
IPC: C12N15/861
Filed: 2015-06-29
Granted: 2018-07-30
Abstract: A composition comprising a gene therapy product for use in the treatment of a dystrophic disease in a subject, advantageously in humans, wherein: - the gene therapy product comprises a nucleic acid sequence encoding a functional microdystrophin; - the composition is systemically administered.
Patent DK-3246403-T3 (DK)
Inventor: HELLINGA HOMME W
IPC: C12N15/90
Filed: 2006-10-18
Granted: 2020-10-26
Abstract: Rationally-designed LAGLIDADG meganucleases and methods of making such meganucleases are provided. In addition, methods are provided for using the meganucleases to generate recombinant cells and organisms having a desired DNA sequence inserted into a limited number of loci within the genome, as well as methods of gene therapy, for treatment of pathogenic infections, and for in vitro applications in diagnostics and research.
Patent DK-0378183-T3 (DK)
Inventor: STRASSMANN G
IPC: A61B50/30
Filed: 1990-01-09
Granted: 1994-11-21
Abstract: The package (10, 40), for receiving material which requires sterilisation, has, in addition to the receiving space (17) for the material, an auxiliary chamber (19) which holds the sterilising agent (20). For the purposes of sterilising the material, sterilising agent (20) is expressed from the auxiliary chamber (19) into the receiving space (17), a predetermined breaking point (21) tearing during this process without the seal between the system and the exterior being broken. <IMAGE>
Patent DK-0392420-T3 (DK)
Inventor: DIALLO ALMADIDI
IPC: H02M3/337
Filed: 1990-04-09
Granted: 1995-04-10
Abstract: This convertor, comprising a DC voltage source supplying a load via at least one switching supply circuit of at least one primary winding of a transformer, is such that this switching supply circuit is a resonant circuit, one element being moreover provided to the secondary of the transformer, of which the value of the impedance at the resonant frequency fR enables the current in this switching supply circuit to be limited to its alternating component alone. <IMAGE>
Patent DK-0464249-T3 (DK)
IPC: B01J29/84
Filed: 1990-07-05
Granted: 1994-04-25
Abstract: 2.1 Molecular sieves belonging to the zeolite type of aluminosilicats have been known for a long time. Their characteristic feature is that their structure comprises AlO2<-> and SiO2<-> tetrahedra whose sequence in the lattice leads to a characteristic pore structure. 2.2 The object is to develop an economically and ecologically advantageous process, in particular a template-free or purely inorganic synthesis process, for the preparation of a wide-pored aluminophosphate molecular sieve or an Si-containing modification thereof having a defined structure. The crystalline aluminophosphate molecular sieve having a microporous structure of wide spaces whose pore inlet openings are greater than or equal to 0.8 nm, which sieve comprises at least AlO2<-> and PO2<+> tetrahedral building blocks and is prepared by crystallisation from a gel-like reaction mixture comprising an aluminium compound, a phosphorus compound, water and, if desired seed crystals, is characterised in that a phosphorus compound containing -P-O-P-building blocks is used for preparing the gel-like reaction mixture and the ready-to-use mixture is treated hydrothermally at temperatures of 95 DEG C to 300 DEG C for 2 - 150 hours. 2.3 Use of the aluminophosphate molecular sieve as catalyst component, as selective adsorbent or as sensor matrix.
Patent DK-0480097-T3 (DK)
Inventor: MARTIN RAIMUND DIPL-ING
IPC: H04R25/02
Filed: 1990-10-12
Granted: 1995-06-06
Abstract: In a hearing aid having a microphone (3), an amplifier (5, 7), an earphone (8) and having at least one data memory (14, 30), it should be possible to determine detailed hearing aid features more easily, particularly in a large number. For this purpose, the data memory (14) forms a part of an identication device (15, 27; 29) and stores at least one hearing aid feature which can be output for identifying the hearing aid (1; 28) via an output means (8; 31; 32) of the identification device, which is associated with the hearing aid.
Patent DK-0432648-T3 (DK)
Inventor: WAETJEN FRANK
IPC: A61P25/04
Filed: 1990-12-06
Granted: 1995-11-06
Abstract: A method of treatment with compounds having the formula <CHEM>  wherein R<1> is hydrogen, C1-6-alkyl which may be branched, C3-7-cycloalkyl, benzyl, phenyl which may be substituted, acyl, hydroxy, C1-6-alkoxy, CH2CO2R' wherein R' is hydrogen or C1-6-alkyl which may be branched, CH2CN, CH2CONR<IV>R<V> wherein R<IV> and R<V> independently are hydrogen or C1-6-alkyl, or CH2C(=NOH)NH2; R<2> is hydrogen, benzyl, C1-6-alkyl which may be branched, or C3-7-cycloalkyl; R<4>, R<5>, R<6>, R<7> independently are hydrogen, C1-6-alkyl which may be branched, phenyl, halogen, C1-6-alkoxy, NO2, CN, SO2NR''R''' wherein R'' and R''' independently are hydrogen or C1-6-alkyl, or CF3; or R<6> and R<7> together form an additional 4 to 7 membered ring which may be aromatic or partial saturated and which may be substituted with halogen, NO2, CF3, CN, SO2NR''R''' wherein R'' and R''' independently are hydrogen or C1-6-alkyl, and R<4> and R<5> have the meanings set forth above, are disclosed, as well as pharmaceutical compositions thereof. Certain of the compounds are novel. The compounds and pharmaceutical compositions containing the compounds are useful in the treatment of central nervous system disorders and especially conditions sensitive to excitatory amino acids.
Patent DK-0405867-T3 (DK)
Inventor: BOLLEN ALEX
IPC: C07K14/00
Filed: 1990-06-22
Granted: 1995-05-22
Abstract: A protein from the Varicella-Zoster Virus glycoproteins consisting of anchor-less gpI, anchor-less gpII, or anchor-less gpIII.
Patent DK-0438992-T3 (DK)
Inventor: STENVALL PETER
IPC: C22C38/00
Filed: 1990-12-13
Granted: 1997-03-10
Abstract: The invention relates to an austenitic stainless steel having a high tensile strength, a high impact strength, a good weldability and a high corrosion resistance, particularly a high resistance to pitting and crevice corrosion. The steel contains in weight-%:  max 0.08 C  max 1.0 Si  more than 0.5 but less than 6 Mn  more than 19 but not more than 28 Cr  more than 17 but not more than 25 Ni  more than 7 but not more than 10 Mo  0.4 - 0.7 N  from traces up to 2 Cu  0 - 0.2 Ce balance essentially only iron, impurities and accessory elements in normal amounts.
Patent DK-0407554-T3 (DK)
Inventor: KEEHAN DONALD J
IPC: C08G59/32
Filed: 1990-01-18
Granted: 1997-10-06
Abstract: The present invention relates to a novel oxirane prepolymer comprising the catalyzed reaction product of an inorganic oxide having at least one hydrolyzable oxygen with a difunctional oxirane oligomer having at least one aromatic moiety and at least one oxirane containing aliphatic moiety, characterized in that substantially all of the hydrolyzable oxygen atoms in said oxide are bonded to said oligomer and there is substantially no bonding between oligomer moieties. The present invention also relates to a novel inorganic oxide containing polymer, said polymer comprising at least three crosslinked prepolymer moieties, each said prepolymer moiety being the reaction product of an inorganic oxide having at least one hydrolyzable oxygen with a difunctional oxirane oligomer having at least one aromatic moiety and at least one oxirane containing aliphatic moiety.
Patent DK-0492522-T3 (DK)
Inventor: ABKE HERBERT
IPC: B65D77/04
Filed: 1991-12-20
Granted: 1995-04-10
Abstract: A reusable container (10) is composed of a shell (11) and an inner lining (12). The inner lining (12) is inherently dimensionally stable and is produced to match the inner contour of the shell (11). The inner lining (12) is seated positively in the shell (11) and the inner lining (12) is produced from a material which is decomposed by ultraviolet rays, or it is made of a material which is biodegradable. Reusable containers (10), which are subjected to intensive soiling or accommodate a product (13) which has great adhesive forces, can be made appropriate for multiple use by means of the inner lining (12). 
<IMAGE>
Patent DK-0458661-T3 (DK)
Inventor: SCHWARTZ JEAN CHARLES
IPC: C07D233/54
Filed: 1991-04-02
Granted: 1997-07-28
Abstract: Therapeutic application of histamine derivatives, new histamine derivative and use of these derivatives for the preparation of medicaments. The invention claims, as medicaments having histamine H3-receptor agonist action, S-[2-(4(5)-imidazolyl)ethyl]isothiourea as well as the new compound of formula <IMAGE> these compounds being useful for the preparation of medicaments intended for use as a hypnotic, sleep promoter, tranquilizer, sedative, anxiolytic, or anti-asthmatic, an anti-inflammatory, in particular bronchial, cutaneous or ocular, or an agent for treating gastric ulcer.
Patent DK-0528925-T3 (DK)
Inventor: CROUZET JOEL
IPC: C12R1/38
Filed: 1991-04-23
Granted: 1994-10-24
Abstract: Novel cloning and/or expression vectors having a wide spectrum of hosts in non mobilizable, Gram-negative bacteria presenting an increased stability. The invention also concerns the use of these vectors, in particular for the production of recombinant proteins and metabolites, or in bioconversion reactions, as well as host cells containing such vectors.
Patent DK-0503383-T3 (DK)
Inventor: NEUHAUSER GERHARD DR
IPC: E04C2/04
Filed: 1992-02-27
Granted: 1996-03-18
Abstract: The gypsum board of high fire resistance with a gypsum core containing cut mineral fibres, preferably glass fibres, contains at least 2% by weight, preferably 5% by weight, of granulated aerated concrete. Preferably, the granulated aerated concrete has a grain size of up to 2 mm, particularly preferably up to 1 mm. The gypsum board can additionally contain up to 2% by weight of vermiculite. It can be laminated on the outside to a glass fibre mat.
Patent DK-0526434-T3 (DK)
Inventor: TURCONI MARCO
IPC: A61K31/41
Filed: 1992-07-30
Granted: 2000-07-17
Abstract: Pharmacologically active benzimidazolone derivatives as 5-HT1A and 5-HT2 receptors, useful in the treatment of CNS disorders of formula:   <CHEM>  wherein R1 and R2 may be at the same time or not a hydrogen atom, halogen, trifluoromethyl, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylthio, C1-6 acyl, carboxyl, C1-6 alkoxy- carbonyl, hydroxy, nitro, amino optionally C1-4 alkyl N-mono or di-substituted, C1-6 acylamino, C1-6 alkoxycarbonylamino, carbamoyl optionally C1-4 alkyl N-mono or di-substituted, cyano, C1-6 alkylsulphinyl, C1-6 alkylsulphonyl, amino sulphonyl optionally C1-4 alkyl N-mono or di-substituted, C1-4 alkyl N-mono or di-substituted aminosulphonylamino, aminosulphonylamino;     R3 is hydrogen, C1-6 alkyl, C2-6 alkenyl or C2-C6 alkynyl;     A is -CO- or -CONH- or it is absent;     B is a straight or branched, saturated or unsaturated C2-6 alkyl;     m and n are both independently an integer from 1 to 3; R4 is an aryl, aralkyl, a heteroaryl or heteroaralkyl group, each group being optionally substituted by one or more substituents selected from halogen, trifluoromethyl, cyano, C1-3 alkoxy, C1-4 alkyland acid addition salts thereof. The process for the preparation of the compounds of formula I as well as pharmaceutical compositions containing them are also described.
Patent DK-0539536-T3 (DK)
Inventor: DUERR WALTER
IPC: A61C8/00
Filed: 1992-04-07
Granted: 1996-09-16
Abstract: PCT No. PCT/DE92/00290 Sec. 371 Date Jan. 13, 1993 Sec. 102(e) Date Jan. 13, 1993 PCT Filed Apr. 7, 1992 PCT Pub. No. WO92/20297 PCT Pub. Date Nov. 26, 1992.Screw unit with a closing screw having a screw head for the aseptic closing of an internal thread of a member and an introduction post in firm, but detachable connection on the closing screw. The detachable connection is formed by a tongue in an end of the post being received in a slot in the screw head which slot terminates inward of a peripheral edge of the screw head.
Patent DK-0587757-T3 (DK)
Inventor: BOTT LAWRENCE LESTER
IPC: C09D175/04
Filed: 1992-06-02
Granted: 1998-09-28
Abstract: Provided are thermosetting powder coating compositions which contain a quaternary ammonium salt or hydroxide having at least one substituent of eight carbons or more and one lower alkyl group. Such quaternary ammonium salts or hydroxides were found to catalyze the curing or cross-linking reaction at lower temperatures in such compositions than previously possible.
Patent DK-0564931-T3 (DK)
Inventor: LEHR GERHARD
IPC: C08K5/3475
Filed: 1993-03-27
Granted: 1995-05-29
Abstract: The invention relates to UV-stabiliser concentrates which comprise, based on the total weight,   A) from 40 to 80 % by weight of at least one thermoplastic polyurethane,   B) from 10 to 30 % by weight of 1,3,5-triglycidylisocyanurate and C) from 10 to 30 % by weight of 2-(2-hydroxy-3,5-di-tert-amylphenyl)-2H-benzotriazole and/or 1,6-hexanediyl bis(3-((3-benzotriazol-N-yl)-4-hydroxy-5-tert-butyl)-phenylpropanoate, to a process for the preparation thereof, and to the use thereof for the stabilisation of TPU against UV and thermal degradation.
Patent DK-0651760-T3 (DK)
Inventor: MARCELO CURTO MARIA JOAO
IPC: C07C62/06
Filed: 1993-10-07
Granted: 2001-05-07
Abstract: The new triterpenoids of general formulae (I), (II), (III) and (IV) where R<1> represents a dialkyl, trialkyl, triphenyl, diphenylalkyl, alkyldiphenyl, dialkylphenyl, haloalkyl, halophenylalkyl, allylalkyl or alkylaminoalkyl group and R<2> represents a carboxyl group, salt or ester, and a process for their preparation which comprises reaction of friedelin with a silylating agent in the presence of a bulky strong base, with kinetic or thermodynamic control, to produce regio-specifically compounds of general formula (I) or (II). Oxidation of (I) or (II) yields the corresponding hydroxy ketones (VII) or (VIII), from which acyl and glycosyl derivatives can be prepared, and further oxidation of the hydroxy ketones (VII) or (VIII) with peracid gives the seco-aldehyde acids (III) or (IV), from which esters or salts can be prepared. Ozonolysis of (I) or (II), followed by reductive treatment, produces the diols of formula (IX) or (X), from which acyl and glycosyl derivatives can be prepared. Oxidation of (I) with a benzoquinone leads to friedel-1-en-2-one (XI) in high yields. Compounds or combinations of compounds (I), (II), (III), (IV), (VI), (VII), (VIII), (IX), (X), (XII), including the acyl and glycosyl derivatives thereof, find application in fungicidal, bactericidal, antitumour and antifeedant compositions.
Patent DK-0606923-T3 (DK)
Inventor: DABI SHMUEL
IPC: C08L67/02
Filed: 1994-01-14
Granted: 2003-07-21
Abstract: The invention presents classes of thermoplastic, biodegradable compositions. Tests indicate that these compositions exhibit good mechanical properties, and readily degrade in the presence of microorganisms. The compositions of this invention are useful for producing injection-molded, thin-walled articles that are capable of appreciably degrading in the sewage system within thirty (30) days.
Patent DK-0651412-T3 (DK)
Inventor: CAPITANELLI CLAUDIO MERLONI TE
IPC: H01H37/48
Filed: 1994-07-08
Granted: 1998-07-27
Abstract: A safety device is described, particularly for a thermostat (1) with an immersion rod system comprising a rod (2) realized with thermoexpansible material, a low thermal dilatation rod (3), provided within said thermoexpansible rod (2), a casing (8), within which said rods (2;3) are introduced, in correspondence of a cavity or cup (7) realized in thermoconductive material, and an interruption mechanism (4) to interrupt a phase of the electric circuit, connected to said rods (2;3), said device comprising a spring element (6), a thermally inert thin disk (9), a calibration element (10) for the safety device and an element (11) for transmitting the strains of the inert disk element (9) to an interruption mechanism for both the phases of the electric circuit, said elements being introduced, in the above mentioned sequence, from the bottom to the above along said low thermal dilatation rod (3), with the calibration element (10) that is regulated in such a way to make the safety device intervening at a temperature higher than the intervention temperature of said interruption mechanism of a phase of the circuit, and said inert disk (9)element being realized with a concavity toward the bottom and having features to trip upside, reversing its concavity, following the dilatation of the thermoexpansible rod (2). <IMAGE>
Patent DK-0671898-T3 (DK)
Inventor: ALLEN KENNETH ALFRED
IPC: A61F13/00
Filed: 1993-11-30
Granted: 1997-12-22
Abstract: An elasticated bandage (1) has knitted therein a geometrical pattern comprising two components (2, 3) which adopt recognisable configurations when the bandage is extended to corresponding predetermined degrees. Preferably, the two components are alternating large and small rectangles (2, 3) arranged with colinear short edges. When the bandage (1) is stretched, the short sides of the rectangles (2, 3) become lengthened. In each case, a point is reached at which the short and long sides of the rectangle becomes square, and this indicates that a pre-determined tension has been reached.
Patent DK-0678194-T3 (DK)
Inventor: JORGENSON RALPH C
IPC: G01N21/55
Filed: 1994-01-05
Granted: 1998-08-10
Abstract: There is disclosed fiber optic sensor which detects a sample in contact with the sensor by surface plasmon resonance (SPR) measurements, as well as methods and apparatus relating thereto. The fiber optic SPR sensor of this invention employs a limited range of incident angles and uses incident light having multiple wavelengths. In preferred embodiments, both an in-line transmission-based fiber optic SPR sensor and a terminated reflection-based fiber optic SPR sensor are disclosed. The fiber optic SPR sensor includes a surface plasmon supporting metal layer in contact with an exposed portion of the optical fiber core, and may optionally contain one or more additional layers deposited on the surface plasmon supporting metal layer. In further embodiments, methods are disclosed for detecting a sample by contacting the sample with the fiber optic SPR sensor of this invention, as well as sensing apparatus which contain the fiber optic SPR sensor in combination with a source of electromagnetic radiation of multiple wavelengths and a detection device.
Patent DK-0711188-T3 (DK)
Inventor: ANNEMAIER DIETER
IPC: A62C2/06
Filed: 1994-07-23
Granted: 1997-12-22
Abstract: PCT No. PCT/EP94/02440 Sec. 371 Date Feb. 28, 1996 Sec. 102(e) Date Feb. 28, 1996 PCT Filed Jul. 23, 1994 PCT Pub. No. WO95/03852 PCT Pub. Date Feb. 9, 1995A device for sealing the gap or void between the outer circumference of a pipe and a hole in a wall the pipe passes through includes a sheet metal casing flexible enough to be bent around the pipe. The inside wall of the casing includes spaced apart inner directed radial projections for containing a swelling agent that is heat activated for filling the void between the housing and pipe in a manner overlapping the gap between the pipe and the wall.
Patent DK-0698720-T3 (DK)
Inventor: REICHEL JOHANN FRIEDRICH
IPC: E06B3/96
Filed: 1995-06-27
Granted: 2000-01-31
Abstract: The method involves moving a corner connector (1) which is self-locking in the hollow chamber by a slide body (2) acting as tension wedge moving against the insert direction (X) of the connector (1). To apply the wedging force the slide body is gripped on its end section (8) protruding over the inclined face (3) by a tension tool which has a support section which extends across the tension direction over the width (B) of the inclined face of the connector up to the mitre surface of the hollow profile. When the wedging force is applied, the support section rests on the mitre surface and the inclined face of the connector on reaching its position aligned with the mitre face bears against the tension tool (12).
Patent DK-0744944-T3 (DK)
Inventor: LIPP RALPH
IPC: A61K9/70
Filed: 1995-02-09
Granted: 2000-04-25
Abstract: PCT No. PCT/EP95/00483 Sec. 371 Date Nov. 8, 1996 Sec. 102(e) Date Nov. 8, 1996 PCT Filed Feb. 9, 1995 PCT Pub. No. WO95/22322 PCT Pub. Date Aug. 24, 1995Transdermal therapeutic systems that contain sex steroids and optionally penetration-enhancers and crystallization inhibitors are described, which are characterized in that they contain dimethyl isosorbide, with the exception of systems that contain active ingredient-containing, non-free-flowing gel phases or 3-keto-desogestrel.
Patent DK-0827563-T3 (DK)
Inventor: BARNES FRAZER JOHN CHARLES
IPC: E04G23/04
Filed: 1996-01-22
Granted: 1999-10-11
Abstract: PCT No. PCT/GB96/00121 Sec. 371 Date Jul. 21, 1997 Sec. 102(e) Date Jul. 21, 1997 PCT Filed Jan. 22, 1996 PCT Pub. No. WO96/22432 PCT Pub. Date Jul. 25, 1996A method and a pre-form for strengthening a substrate structural member. Layers are applied to a surface of a substrate where the layers include dry fibre reinforcement materials. A reduced pressure is then applied to the layers and a curable resin is introduced to the layers such that the resin is drawn therethrough until the interstices therein are substantially filled with the resin. The resin is then cured. The layers are preferably woven fabric and may include resin distribution layers of relatively low weave density and high permeability and reinforcement layers of higher weave density and lower permeability. The layers may be provided as a pre-form.
Patent DK-0814770-T3 (DK)
Inventor: JORDAN ANDREW WILLIAM
IPC: A61K9/00
Filed: 1996-03-01
Granted: 2001-11-05
Abstract: A process for the preparation of a solid pharmaceutical dosage form comprising a carrier and, as active ingredient, a compound which exists, in solution, in an equilibrium between a free acid or free base form and a salt form, and for which there is a difference in volatility between the free acid or free base form and the salt form. The process includes the steps of solidifying a mixture of the compound and carrier in a solvent, and subsequently removing the solvent from the solidified mixture. A pH modifier is added to the mixture prior to solidification to shift the equilibrium to favor the less volatile form of the active ingredient.
Patent DK-0833609-T3 (DK)
Inventor: TSAO FU-PAO
IPC: A61K47/24
Filed: 1996-06-12
Granted: 2002-02-18
Abstract: Compositions and methods for reducing the decomposition rate of polymeric bioadhesives and viscosity enhancers, such as poly(acrylic acids). The compositions include at least one strong, stable chelating agent, preferably an organophosphorous compound such as diethylene triamine penta(methylene phosphonic acid). These biocompatible compositions are especially useful in the ophthalmic field.
Patent DK-0789096-T3 (DK)
Inventor: VENNEMAN RENE
IPC: D01F6/06
Filed: 1997-02-05
Granted: 2000-10-02
Abstract: The present invention relates to polypropylene fibers and nonwoven fabrics produced from spunlaid or staple fibers having improved natural bulk. Said polypropylene fibers are made of a blend of sPP and iPP.